These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 34794)

  • 21. Natural killer cells and their possible relevance to transplantation biology.
    Herberman RB
    Transplantation; 1982 Jul; 34(1):1-7. PubMed ID: 6214877
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia.
    Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):377-9. PubMed ID: 238679
    [No Abstract]   [Full Text] [Related]  

  • 23. Natural killer (NK) cells and their possible roles in resistance against disease.
    Herberman RB
    Clin Immunol Rev; 1981; 1(1):1-65. PubMed ID: 6219848
    [No Abstract]   [Full Text] [Related]  

  • 24. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
    de Witte T; Preijers F; Schattenberg A
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463
    [No Abstract]   [Full Text] [Related]  

  • 25. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.
    Weiden PL; Flournoy N; Thomas ED; Prentice R; Fefer A; Buckner CD; Storb R
    N Engl J Med; 1979 May; 300(19):1068-73. PubMed ID: 34792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Graft-versus-Host Reaction: a pathogenetic mechanism of experimental and human disease.
    Seemayer TA
    Perspect Pediatr Pathol; 1979; 5():93-136. PubMed ID: 43960
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation.
    Ikehara S; Nakamura T; Sekita K; Muso E; Yasumizu R; Ohtsuki H; Hamashima Y; Good RA
    Prog Clin Biol Res; 1987; 229():131-46. PubMed ID: 3299389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological dysregulation after bone-marrow transplantation in patients with severe combined immunodeficiency.
    Virelizier JL; Durandy A; Ballet JJ; Griscelli C
    Pathol Biol (Paris); 1978 Jan; 26(1):21-2. PubMed ID: 29268
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors.
    Lamb LS; Gee AP; Henslee-Downey PJ; Geier SS; Hazlett L; Pati AR; Godder K; Abhyankar SA; Turner MW; Lee C; Harris WG; Parrish RS
    Bone Marrow Transplant; 1998 Mar; 21(5):461-71. PubMed ID: 9535038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rejection of bone marrow cells by irradiated mice: NK and T cells recognize different antigens.
    Bennett M; Kumar V; Mikhael A; Murphy WJ; Rembecki RM; Sentman CL; David CS
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):5-11. PubMed ID: 3321646
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft-versus-host disease in recipients of syngeneic bone marrow.
    Olsson L; Kiger N; Mathé G
    Lancet; 1980 Feb; 1(8162):253. PubMed ID: 6101696
    [No Abstract]   [Full Text] [Related]  

  • 35. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
    Ringdén O; Deeg HJ; Beschorner W; Slavin S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
    [No Abstract]   [Full Text] [Related]  

  • 37. Bone marrow transplantation. Influence of T lymphocytes on the process of differentiation and proliferation of bone marrow cells.
    Vitale B; Burek V; Plavljanić D
    Transplant Proc; 1977 Mar; 9(1):269-72. PubMed ID: 17193
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulation of immune responses by T cells.
    Jiang H; Chess L
    N Engl J Med; 2006 Mar; 354(11):1166-76. PubMed ID: 16540617
    [No Abstract]   [Full Text] [Related]  

  • 39. Manipulation of T cells in the transplant inoculum.
    Kersey J
    Int J Cell Cloning; 1986; 4 Suppl 1():122-6. PubMed ID: 3528329
    [No Abstract]   [Full Text] [Related]  

  • 40. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.